perfluorooctane sulfonic acid has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basaly, V; Bihaqi, SW; Hill, J; Marques, E; Slitt, AL; Zawia, NH | 1 |
| Leng, S; Liu, W; Luo, F; Qin, H; Zhang, Q; Zhang, Z; Zhao, H | 1 |
2 other study(ies) available for perfluorooctane sulfonic acid and Alzheimer Disease
| Article | Year |
|---|---|
Developmental Perfluorooctanesulfonic acid (PFOS) exposure as a potential risk factor for late-onset Alzheimer's disease in CD-1 mice and SH-SY5Y cells.
Topics: Alkanesulfonic Acids; Alzheimer Disease; Animals; Animals, Newborn; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Fluorocarbons; Glycogen Synthase Kinase 3 beta; Humans; Locomotion; Male; Maze Learning; Mice; Pregnancy; Risk Factors | 2021 |
Developmental perfluorooctane sulfonate exposure results in tau hyperphosphorylation and β-amyloid aggregation in adults rats: Incidence for link to Alzheimer's disease.
Topics: Alkanesulfonic Acids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Female; Fluorocarbons; Incidence; Phosphorylation; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; tau Proteins | 2016 |